CCM
OM icon

CAAS Capital Management’s Outset Medical OM Stock Holding History

CAAS Capital Management’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-3,566
Closed -$3.04M – 1341
2020
Q4 		$3.04M Buy
3,566
+1,566
+78% +$1.21M 0.03% 413
2020
Q3 		$1.5M Buy
+2,000
New +$1.64M 0.04% 294

Other funds holding OM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WP
Warburg Pincus New York $343M AUM 18.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DCP
D1 Capital Partners New York $11.2B AUM 15.78% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CAAS Capital Management's OM Position: Q1 2021 in Review

CAAS Capital Management sold out of Outset Medical (OM) in Q1 2021, closing a stake of 3,566 shares — an estimated $3.04M sold.

CAAS Capital Management first reported a position in OM in Q3 2020 and held it in 2 quarters. The position peaked at $3.04M in Q4 2020. 111 funds tracked by Wall St. Rank hold OM as of Q1 2021.

  • CAAS Capital Management reported no remaining Outset Medical position as of Q1 2021 after selling out during the quarter.
  • CAAS Capital Management sold 3,566 Outset Medical shares in Q1 2021, an estimated $3.04M.
  • CAAS Capital Management first reported a position in Outset Medical in Q3 2020 and held it in 2 quarters.
  • CAAS Capital Management's Outset Medical position peaked at $3.04M in Q4 2020.
  • 111 funds tracked by Wall St. Rank held Outset Medical as of Q1 2021.

Based on CAAS Capital Management's 13F filing for Q1 2021, filed 17 May 2021.